Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance (Q38191280)

30 August 2017

1 reference

title

Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance (English)

1 reference

30 August 2017

M Andreani

1

1 reference

30 August 2017

M Testi

series ordinal

2

1 reference

30 August 2017

G Lucarelli

series ordinal

3

1 reference

30 August 2017

publication date

1 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

83

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

137-146

1 reference

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

30 August 2017

cites work

1 reference

Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up

21 January 2018

1 reference

New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years

21 January 2018

1 reference

Hematopoietic stem cell transplantation in thalassemia

21 January 2018

1 reference

21 January 2018

1 reference

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia

21 January 2018

1 reference

Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia

21 January 2018

1 reference

In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study

21 January 2018

1 reference

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

21 January 2018

1 reference

Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation

21 January 2018

1 reference

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.

21 January 2018

1 reference

Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation

21 January 2018

1 reference

Immuno-intervention for the induction of transplantation tolerance through mixed chimerism

21 January 2018

1 reference

HLA-mismatched renal transplantation without maintenance immunosuppression

21 January 2018

1 reference

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease

21 January 2018

1 reference

Induction of tolerance through mixed chimerism

21 January 2018

1 reference

Induction of foxP3 regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants

21 January 2018

1 reference

Blood Group Chimeras: A Review

21 January 2018

1 reference

Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.

21 January 2018

1 reference

Loss of mismatched HLA in leukemia after stem-cell transplantation.

21 January 2018

1 reference

Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease

21 January 2018

1 reference

Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies

21 January 2018

1 reference

The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation.

21 January 2018

1 reference

Defining the intensity of conditioning regimens: working definitions

21 January 2018

1 reference

Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need

21 January 2018

1 reference

Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

21 January 2018

1 reference

Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation

21 January 2018

1 reference

Lineage-specific chimerism analysis in nucleated cells, T cells and natural killer cells after myeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study

21 January 2018

1 reference

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

21 January 2018

1 reference

Monitoring of donor chimerism in sorted CD34 peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation

21 January 2018

1 reference

Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation

21 January 2018

1 reference

Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.

21 January 2018

1 reference

Pregnancy, microchimerism, and the maternal grandmother

21 January 2018

1 reference

Translational studies in hematopoietic cell transplantation: Treatment of hematologic malignancies as a stepping stone to tolerance induction

21 January 2018

1 reference

Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero

21 January 2018

1 reference

Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation

21 January 2018

1 reference

Combining Treg therapy with mixed chimerism: Getting the best of both worlds

21 January 2018

1 reference

Tolerance and chimerism after renal and hematopoietic-cell transplantation

21 January 2018

1 reference

Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients.

21 January 2018

1 reference

Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera

21 January 2018

1 reference

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

21 January 2018

1 reference

Methods for in vitro generation of human type 1 regulatory T cells

21 January 2018

1 reference

Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.

21 January 2018

1 reference

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.

21 January 2018

1 reference

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

21 January 2018

1 reference

CD4 Foxp3 regulatory T cell therapy in transplantation

21 January 2018

1 reference

Clinical tolerance in allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TAN.12313

1 reference

30 August 2017

1 reference